Autoantibody profile in the sera of women with hyperprolactinemia

Dan Buskila, Meir Berezin, Hanan Gur, Hun Chi Lin, Iyad Alosachie, Jeff W. Terryberry, Noorie Barka, B. Shen, James B. Peter, Yehuda Shoenfeld

Research output: Contribution to journalArticlepeer-review

61 Scopus citations

Abstract

Prolactin (PRL) has been implicated as an importantin vivomodulator of cellular and humoral immunity. In order to elucidate the impact of elevated serum PRL levels on the immune system, we measured circulating autoantibodies in the serum of 33 hyperprolactinemic (HPRL) women and in 19 healthy women with normal PRL levels. All sera were examined for the presence of autoantibodies against 15 different antigens, including: ssDNA, dsDNA, histones (H2AH2B), Sm, RNP, SS-A/Ro, SS-B/La, cardiolipin, Scl-70, Jo1, collagen, glomerular basement membrane (GBM), pyruvate dehydrogenase (PDH), proteinase-3 (PR3) and MPO. Twenty-five of 33 (75.7%) HPRL women were found to have at least one autoantibody, while none of the 19 women with normal PRL had any. Eight HPRL women had seven or more (up to nine) different autoantibodies. Some of the autoantibodies were more frequently expressed than others, namely: anti-ss-DNA, anti-dsDNA, anti-Sm, anti-PDH and anti-SS-A/Ro. Autoantibodies to the autoantigens tested are common in a variety of autoimmune and rheumatic disorders including systemic lupus erythematosus (SLE), Sjoügren’s syndrome, mixed connective tissue disease (MCTD), scleroderma, primary biliary cirrhosis (PBC), polymyositis/dermatomyositis and vasculitis. Yet none of the HPRL women whose serum was found to contain high titers of autoantibodies presented with symptoms related to the respective autoimmune disorders. Our results support the role of PRL in the regulation of immune responses in man.

Original languageEnglish
Pages (from-to)415-424
Number of pages10
JournalJournal of Autoimmunity
Volume8
Issue number3
DOIs
StatePublished - 1 Jan 1995

Fingerprint

Dive into the research topics of 'Autoantibody profile in the sera of women with hyperprolactinemia'. Together they form a unique fingerprint.

Cite this